Home » Newsletters » BioWorld Science

BioWorld Science

March 19, 1998

View Archived Issues

Estrogen: a potential agent for prevention of dementia?

COX-1 inhibition is more effective than COX-2 inhibition in a chronic inflammation model

Company Profile: Sinogen

Dusa: year-end 1997 highlights

Potent inhibitors of IL-1beta and TNF-alpha production prepared at Nisshin Flour Milling

Abbott describes novel lead structure for selective COX-2 inhibitors

AHP reports novel neuroprotectants

Company Profile: SuperGen

U.S. university scientists report novel muscarinic agonists

BB-10010 has myelosuppressive and progenitor cell-mobilizing effects in humans

LXR files IND for CP-Cardiosol

Analysis of statin results confirms beneficial clinical effects of lipid lowering on mortality

Phase II ImmTher trial begins in pediatric cancer patients

FDA clears free PSA blood test

LifeCell will be awarded U.S. patent for blood cell preservation technology

Mechanism of chemopreventive activity of resveratrol identified

GABA-A receptor ligands under evaluation at Neurogen

Ixion succeeds in lowering urinary oxalate levels with IxC1-62/47

Creative BioMolecules: year-end 1997 highlights

Fuisz closes acquisition of Rentschler

SmithKline Beecham and Ligand begin leptin-obesity collaboration

Spongiform encephalopathies advisory committee meeting scheduled

Collagenex amends NDA for Periostat

Roche benzodiazepines go head-to-head with midazolam

CytRx begins patient enrollment for Flocor phase III trial

Combivir approved in E.U.

Novel enzyme inhibitors discovered at California institute

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...